These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1317565)

  • 1. A purified recombinant organophosphorus acid anhydrase protects mice against soman.
    Broomfield CA
    Pharmacol Toxicol; 1992 Jan; 70(1):65-6. PubMed ID: 1317565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A purified recombinant organophosphorus acid anhydrase protects mice against soman.
    Broomfield CA
    Chem Biol Interact; 1993 Jun; 87(1-3):279-84. PubMed ID: 8393744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cresylbenzodioxaphosphorin oxide pretreatment alters soman-induced toxicity and inhibition of tissue cholinesterase activity of the rat.
    Jimmerson VR; Shih TM; Maxwell DM; Mailman RB
    Toxicol Lett; 1989 Jul; 48(1):93-103. PubMed ID: 2749782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity.
    Maxwell DM; Brecht KM; O'Neill BL
    Toxicol Lett; 1987 Nov; 39(1):35-42. PubMed ID: 3672554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic subcellular localization of cresylbenzodioxaphosphorin oxide (CBDP)-sensitive soman binding sites.
    Little JS; Maxwell DM; Fox-Talbot MK; Brecht K; Lenz DE
    Biochem Pharmacol; 1990 Oct; 40(8):1733-7. PubMed ID: 2242010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM; Koplovitz I
    J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice.
    Shapira S; Kadar T; Cohen G; Chapman S; Raveh L
    Arch Toxicol; 1990; 64(8):663-8. PubMed ID: 2090035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organophosphorus acid anhydride hydrolase activity in human butyrylcholinesterase: synergy results in a somanase.
    Millard CB; Lockridge O; Broomfield CA
    Biochemistry; 1998 Jan; 37(1):237-47. PubMed ID: 9425044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pretreatment with CBDP on the toxicokinetics of soman stereoisomers in rats and guinea pigs.
    Due AH; Trap HC; Van Der Wiel HJ; Benschop HP
    Arch Toxicol; 1993; 67(10):706-11. PubMed ID: 8135661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced stereoselective hydrolysis of toxic organophosphates by directly evolved variants of mammalian serum paraoxonase.
    Amitai G; Gaidukov L; Adani R; Yishay S; Yacov G; Kushnir M; Teitlboim S; Lindenbaum M; Bel P; Khersonsky O; Tawfik DS; Meshulam H
    FEBS J; 2006 May; 273(9):1906-19. PubMed ID: 16640555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
    Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
    Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and biochemical evidence for the lack of significant hydrolysis of soman by a Flavobacterium parathion hydrolase.
    Pogell BM; Rowland SS; Steinmann KE; Speedie MK; Hoskin FC
    Appl Environ Microbiol; 1991 Feb; 57(2):610-1. PubMed ID: 1849715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
    Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
    Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of aliesterase as a detoxification mechanism for soman (Pinacolyl methylphosphonofluoridate) in mice.
    Clement JG
    Biochem Pharmacol; 1984 Dec; 33(23):3807-11. PubMed ID: 6508835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis against organophosphate poisoning by an enzyme hydrolysing organophosphorus compounds in mice.
    Ashani Y; Rothschild N; Segall Y; Levanon D; Raveh L
    Life Sci; 1991; 49(5):367-74. PubMed ID: 1649941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of 2-/o-cresyl/-4 H-1 : 3 : 2-benzodioxa-phosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy.
    Bosković B
    Arch Toxicol; 1979 Jul; 42(3):207-16. PubMed ID: 475595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamates of (hydroxyphenoxy)methyl heteroaromatic salts as acetylcholinesterase inhibitors and protective agents against organophosphorus compounds.
    Sundberg RJ; Dalvie D; Cordero J; Sabat M; Musallam HA
    Chem Res Toxicol; 1993; 6(4):500-5. PubMed ID: 8374048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoisomers of soman (pinacolyl methylphosphonofluoridate): inhibition of serum carboxylic ester hydrolase and potentiation of their toxicity by CBDP (2-(2-methylphenoxy)-4H-1,3,2-benzodioxaphosphorin-2-oxide) in mice.
    Clement JG; Benschop HP; DeJong LP; Wolthuis OL
    Toxicol Appl Pharmacol; 1987 Jun; 89(1):141-3. PubMed ID: 3590185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium pentobarbital alteration of the toxicity and distribution of soman (pinacolyl methylphosphonofluoridate) in mice.
    Clement JG
    Biochem Pharmacol; 1984 Feb; 33(4):683-5. PubMed ID: 6704186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.